Awards for Excellence in Human Research Protection for 2013 were announced
Awards for Excellence in Human Research Protection for 2013 were announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute.
Winner of the Annual Award for Innovation was the Professionalism and Integrity in Research Program for its P.I. Program Workshop. Created by Dr. James M. DuBois and colleagues at Saint Louis University and Washington University in St. Louiswith funding from the National Institutes of Health, this serves as the first remediation program for researchers who engaged in wrongdoing or persistent noncompliance. The program was developed by a team of clinical, educational, industrial-organizational, and social psychologists, with guidance from experts in research ethics, regulations, and administration.
Winner of the Annual Award for Lifetime Achievement was Will C. van den Hoonaard. Dr. van den Hoonaard has served the research-ethics community in various capacities including the Canadian Interagency Panel on Research Ethics, involvement in research-ethics journals, numerous guest lectures, and author and editor of several books. Dr. van den Hoonaard is Professor Emeritus at the University of New Brunswick, and Research Associate at the Atlantic Centre for Qualitative Research and Analysis, Saint Thomas University. Both universities are located in Fredericton, NB, Canada.
Recipients of an Award of Excellence for Best Practice included:
Recipients of an Award of Excellence for Lifetime Achievement included:
"The Award program offers positive recognition for excellence in the field of human research protection," said Dr. Goldschmidt. "This year's awards continue the high standard that we have seen since the program began. We congratulate the winners." Awards are given for demonstrated excellence in promoting the well being of people who participate in research. The Health Improvement Institute created this Award program. This year's judges were drawn from academic, compliance, consulting, health services, legal, and research review organizations.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.